DarioHealth Statistics
Total Valuation
DarioHealth has a market cap or net worth of $35.91 million. The enterprise value is $31.00 million.
Market Cap | 35.91M |
Enterprise Value | 31.00M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, before market open.
Earnings Date | Aug 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
DarioHealth has 29.92 million shares outstanding. The number of shares has increased by 24.93% in one year.
Shares Outstanding | 29.92M |
Shares Change (YoY) | +24.93% |
Shares Change (QoQ) | +19.17% |
Owned by Insiders (%) | 14.16% |
Owned by Institutions (%) | 29.99% |
Float | 24.10M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.89 |
Forward PS | 0.84 |
PB Ratio | 0.46 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.63 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.39.
Current Ratio | 2.95 |
Quick Ratio | 2.67 |
Debt / Equity | 0.39 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -84.80% and return on invested capital (ROIC) is -56.82%.
Return on Equity (ROE) | -84.80% |
Return on Assets (ROA) | -52.40% |
Return on Capital (ROIC) | -56.82% |
Revenue Per Employee | $64,776 |
Profits Per Employee | -$203,724 |
Employee Count | 294 |
Asset Turnover | 0.17 |
Inventory Turnover | 2.34 |
Taxes
Income Tax | -1.93M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.80% in the last 52 weeks. The beta is 1.53, so DarioHealth's price volatility has been higher than the market average.
Beta (5Y) | 1.53 |
52-Week Price Change | -70.80% |
50-Day Moving Average | 1.39 |
200-Day Moving Average | 1.66 |
Relative Strength Index (RSI) | 44.94 |
Average Volume (20 Days) | 95,013 |
Short Selling Information
The latest short interest is 1.54 million, so 5.16% of the outstanding shares have been sold short.
Short Interest | 1.54M |
Short Previous Month | 1.49M |
Short % of Shares Out | 5.16% |
Short % of Float | 6.41% |
Short Ratio (days to cover) | 19.83 |
Income Statement
In the last 12 months, DarioHealth had revenue of $19.04 million and -$59.90 million in losses. Loss per share was -$1.68.
Revenue | 19.04M |
Gross Profit | 5.25M |
Operating Income | -61.64M |
Pretax Income | -55.71M |
Net Income | -59.90M |
EBITDA | -50.61M |
EBIT | -55.71M |
Loss Per Share | -$1.68 |
Balance Sheet
The company has $35.34 million in cash and $30.44 million in debt, giving a net cash position of $4.90 million or $0.16 per share.
Cash & Cash Equivalents | 35.34M |
Total Debt | 30.44M |
Net Cash | 4.90M |
Net Cash Per Share | $0.16 |
Equity (Book Value) | 78.03M |
Book Value Per Share | 2.61 |
Working Capital | 34.71M |
Cash Flow
In the last 12 months, operating cash flow was -$38.73 million and capital expenditures -$566,000, giving a free cash flow of -$39.30 million.
Operating Cash Flow | -38.73M |
Capital Expenditures | -566,000 |
Free Cash Flow | -39.30M |
FCF Per Share | -$1.14 |
Margins
Gross margin is 27.56%, with operating and profit margins of -323.65% and -314.51%.
Gross Margin | 27.56% |
Operating Margin | -323.65% |
Pretax Margin | -292.52% |
Profit Margin | -314.51% |
EBITDA Margin | -265.73% |
EBIT Margin | -292.52% |
FCF Margin | -206.35% |
Dividends & Yields
DarioHealth does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -24.93% |
Shareholder Yield | -24.93% |
Earnings Yield | -166.80% |
FCF Yield | -109.44% |
Analyst Forecast
The average price target for DarioHealth is $4.05, which is 237.50% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $4.05 |
Price Target Difference | 237.50% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | 43.95% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 18, 2019. It was a reverse split with a ratio of 1:20.
Last Split Date | Nov 18, 2019 |
Split Type | Reverse |
Split Ratio | 1:20 |
Scores
DarioHealth has an Altman Z-Score of -4.2 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -4.2 |
Piotroski F-Score | 1 |